Dr. Lisa Crossley reports

RELIQ HEALTH TECHNOLOGIES, INC. PROVIDES UPDATE ON STATUS OF MANAGEMENT CEASE TRADE ORDER

Reliq Health Technologies Inc. has provided this update on the status of a management cease trade order granted on Oct. 31, 2023, by the British Columbia Securities Commission under National Policy 12-203, Management Cease Trade Order. On Oct. 31, 2023, the Company announced that, for reasons disclosed in the news release, there would be a delay in the filing of its financial statements and accompanying management's discussion and analysis for the fiscal year ended June 30, 2023 (the "Annual Filings") beyond the period prescribed under applicable Canadian securities laws (the "Default Announcement").

"We continue to work to finalize the annual audited financials as soon as possible," said Dr. Lisa Crossley, CEO at Reliq Health Technologies, Inc. "We regret the inconvenience to our shareholders and thank them for their patience. We were able to connect the auditors with the last customer on their list for a virtual meeting late last week, and the final outstanding AR Confirmation letters from customers were received by the auditors on Friday. Our clients are busy healthcare professionals with more pressing clinical priorities, so this aspect of the audit has involved considerably more time than anticipated. We would like to thank our clients for their cooperation. The Company will notify shareholders of the date and login details for the webinar to discuss the annual audited financials as soon as the filing date is finalized."

During the MCTO, the general investing public will continue to be able to trade in the Company's listed common shares. However, the Company's chief executive officer and chief financial officer will not be able to trade in the Company's shares.

Other than as disclosed in this news release, there are no material changes to the information contained in the Default Announcement. The Company confirms that it intends to satisfy the provisions of NP 12- 203 and will continue to issue bi-weekly default status reports for so long as it remains in default of the Annual Filings requirement. The Company expects to file the Annual Filings on or before December 29, 2023, at which time the Company will issue a news release announcing the completion of the filings.

Reliq Health

Reliq Health Technologies is a rapidly growing global healthcare technology company that specializes in developing innovative Virtual Care solutions for the multi-billion dollar Healthcare market. Reliq's powerful iUGO Care platform supports care coordination and community-based virtual healthcare. iUGO Care allows complex patients to receive high quality care at home, improving health outcomes, enhancing quality of life for patients and families and reducing the cost of care delivery. iUGO Care provides real-time access to remote patient monitoring data, allowing for timely interventions by the care team to prevent costly hospital readmissions and ER visits. Reliq Health Technologies trades on the TSX Venture under the symbol RHT, on the OTC as RQHTF and on the Frankfurt Stock Exchange under the WKN: A2AJTB.

We seek Safe Harbor.